Diabetes in the elderly: problems of care and service provision.
Diabetes is common in the elderly and old UK citizens, affecting between 10% and 25%. There is considerable associated morbidity and mortality, with dementia being a common problem. The diabetic elder is also at risk of drug side-effects. Most of the evidence base for treatment is based on trials performed in younger diabetic subjects or older nondiabetic subjects; however, we can practice evidence-biased medicine whilst awaiting the results of ongoing trials. The older persons national service framework (NSF) may share some similarities with the diabetes NSF; it was 1 year late, and had no clear funding, amongst several other worries. Residential care, which is more likely to be required by diabetic elders, is also under-funded with major concerns about the quality of care for the diabetic resident. The little evidence that we have regarding care of the older diabetic person also suggests inadequacies. Given the likelihood that we will have to manage with present resources, managed clinical networks may be one way to cope.
Croxson
S
S
Department of Medicine for the Elderly, Bristol Royal Infirmary, Bristol, UK. simon.croxson@virgin.net
D000368:Aged; D015415:Biomarkers / Q000097:blood; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000097:blood / Q000451:nursing / Q000628:therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006299:Health Services for the Aged / Q000458:organization & administration*; D018577:Homebound Persons; D006707:Homes for the Aged; D006801:Humans; D013222:State Medicine / Q000458:organization & administration*; D006113:United Kingdom
D015415:Biomarkers; D006442:Glycated Hemoglobin